Special Issue "Treatment of Dystonia with Botulinum Toxins"
Deadline for manuscript submissions: closed (28 February 2020).
The treatment of focal dystonia has been revolutionized by botulinum toxins. First approved in 1989 by the US Food and Drug Administration, botulinum toxin injection is now the worldwide mainstay therapy for this often painful and disabling condition. There are several safe and effective botulinum toxins, and more are under development.
This Special Issue of Toxins focuses on treatment of the different focal dystonias and provides an overview of available botulinum products and relevant practice guidelines. Included in this Special Issue are in-depth discussions of the treatment of cervical dystonia, blepharospasm, oromandibular dystonia, task specific dystonia, and other limb dystonias.
Prof. David Charles
Prof. Peter Hedera
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cervical dystonia
- oromandibular dystonia
- botulinum toxin